RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE belongs to a group of medicines called Gonadotropins. It is used to treat infertility in women (oligo-anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure) and to stimulate sperm production in men.
RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE contains a follicle-stimulating hormone, which acts by developing and ripening several follicles and inducing the ovulation procedure. In infertile men, RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE is used along with other medicines to help produce sperm.
RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE may cause certain side effects, such as headache, vomiting, diarrhoea, abdominal cramps, abdominal pain, fever, sore throat, sneezing, and pain at the injection site. These side effects are usually mild and temporary. RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE will be administered by a trained healthcare doctor.
Before receiving RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE, inform your doctor if you have a known allergy to RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE or any contents present in it. RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE is not recommended for patients with primary ovarian failure, and primary testicular failure, pregnant and breastfeeding women. Inform your doctor about your complete medical and medication history before receiving RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE to rule out any side effects.
Female infertility, Hypogonadism.
RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE contains ‘follicle-stimulating hormone used to treat fertility problems (usually given along with other medicines). In females, RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE develops and ripens several follicles (containing eggs necessary for fertilization) in women undergoing assisted reproductive technologies (a procedure that helps to get pregnant). It also helps to induce the ovulation procedure (releasing an egg from the ovary). In males, it helps replenish the deficient testosterone (anabolic steroid and primary sex hormone in males) levels and helps produce sperm cells.
Before receiving RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE, inform your doctor if you have any known allergies to this medicine or any contents present in it. Inform your doctor about your complete medical and medication history before receiving RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE to rule out any side effects. RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE is not recommended for patients with primary ovarian failure, primary testicular failure, an untreated or uncontrolled disorder of the thyroid gland, pituitary gland, or adrenal gland, abnormal vaginal bleeding, ovarian cyst, breast cancer, uterine cancer, and cancer of ovaries, testicle, hypothalamus, or pituitary gland. Inform your doctor about your complete medical and medication history before receiving RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE to rule out any side effects. Inform your doctor if you have/had any history of stroke, blood clot, stomach surgery, unusual vaginal bleeding, PCOD, and liver/kidney disease. This medicine is contraindicated in pregnant women, breastfeeding mothers and children.
Drug-Drug Interactions: RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE may interact with ganirelix, OTC medicines, vitamins and herbal supplements. Before starting the treatment with RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE, inform your doctor about your ongoing medicines and medication history.
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE should not be used in patients with adrenal dysfunction, thyroid dysfunction, ovarian cysts (fluid-filled sacs in ovaries), and tumours of ovaries, womb, or breast.
It is unknown whether RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE interacts with alcohol. Please consult your doctor.
Do not use RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE if you are pregnant. You may need to have a negative pregnancy test before starting this treatment.
RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE is not recommended for use in breastfeeding women.
RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE does not effect your ability to drive.
If you have a pre-existing or a history of liver disease, inform your doctor before receiving RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE.
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
RECOMBINANT HUMAN FOLLICLE STIMULATING HORMONE is not intended for use in children.
Female Infertility: When a woman cannot become pregnant within a year of trying without the use of contraception, then the condition is called female infertility. If a woman gets pregnant but experiences miscarriages or stillbirths, it is also included in infertility. It can occur due to ovulation disorders (problems with ovaries), fallopian tube damage, and uterus or cervix problems. The risk factors can be age, being overweight or obese, smoking, alcoholism, and the presence of sexually transmitted infections.
Hypogonadism: It is a condition in which the gonads (testes in men and ovaries in women) produce insufficient sex hormones. Sex hormones are responsible for secondary sexual characteristics. This mainly occurs due to autoimmune disorders, genetic disorders, severe infections, pituitary disorders, and inflammatory diseases.